Learn if AZEDRA
could be right for you
AZEDRA is the first and only approved treatment for advanced
pheochromocytoma and paraganglioma.
Not an actual patient.
Learn about pheochromocytoma and paraganglioma
Pheochromocytoma and paraganglioma are rare tumors that cause a variety of serious symptoms. Because they are unique tumors, the goals for treating them are also unique.
View patient resources and
find support services
Learn about the AZEDRA support program, explore
Frequently Asked Questions and a Glossary, and
download the AZEDRA Patient Brochure.